Literature DB >> 29670898

Effects of Withania somnifera on Reproductive System: A Systematic Review of the Available Evidence.

Ramin Nasimi Doost Azgomi1, Afshar Zomorrodi2, Hossein Nazemyieh3, Seyed Mohammad Bagher Fazljou1, Homayoun Sadeghi Bazargani4,5, Fatemeh Nejatbakhsh6, Arezoo Moini Jazani1, Yadollah Ahmadi AsrBadr7.   

Abstract

INTRODUCTION: Withania somnifera (WS) also known as ashwagandha is a well-known medicinal plant used in traditional medicine in many countries for infertility treatment. The present study was aimed at systemically reviewing therapeutic effects of WS on the reproductive system.
METHODS: This systematic review study was designed in 2016. Required data were obtained from PubMed, Scopus, Google Scholar, Cochrane Library, Science Direct, Web of Knowledge, Web of Science, and manual search of articles, grey literature, reference checking, and expert contact.
RESULTS: WS was found to improve reproductive system function by many ways. WS extract decreased infertility among male subjects, due to the enhancement in semen quality which is proposed due to the enhanced enzymatic activity in seminal plasma and decreasing oxidative stress. Also, WS extract improved luteinizing hormone and follicular stimulating hormone balance leading to folliculogenesis and increased gonadal weight, although some animal studies had concluded that WS had reversible spermicidal and infertilizing effects in male subjects.
CONCLUSION: WS was found to enhance spermatogenesis and sperm related indices in male and sexual behaviors in female. But, according to some available evidences for spermicidal features, further studies should focus on the extract preparation method and also dosage used in their study protocols.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29670898      PMCID: PMC5833251          DOI: 10.1155/2018/4076430

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


1. Introduction

Infertility is a complicated problem with physiologic, psychologic, and economic aspects. Infertility is defined as the inability to conceive after one year of unprotected sexual intercourse [1]. About 15 percent of couples worldwide suffer infertility [2]. One in six couples is involved with infertility during their reproductive age. Based on World Health Organization report, 60–80 million couples suffer from failure of fertility worldwide [3]. It may be difficult to diagnose the reason for infertility but it may include either dysregulation of sex hormonal axis in both men and women or anatomical anomalies [4]. According to different studies, approximately 20%–50% of infertility is due to male, 40% is due to female factors, and 25% of causes are unknown [1, 5]. The causes of male infertility are classified as pretesticular, testicular, posttesticular, and unknown. Sperm abnormality causes 30%–40% of all infertility [6]. Pretesticular causes include disorders in the hypothalamus-pituitary-gonadal axis, systemic diseases, sexual dysfunction, and psychopathy. Testicular dysfunction due to multiple reasons as infection, trauma, varicocele, cryptorchidism, chromosomal anomalies, alcohol, cigarettes, drugs, and radiation is another cause of male infertility. Posttesticular disorders comprise the abnormalities in sperm transfer such as obstruction or dysfunction of epididymis and ductus deferens, immunological defects, and anatomical abnormalities like hypospadias [7, 8]. Different etiologies of female infertility include ovarian diseases, tubal disorders, endometriosis, uterine pathologies, cervical problems, congenital anomalies, and dysfunction of the hypothalamus-pituitary-ovarian axis and systemic diseases [1, 9]. Treatment of infertility may vary due to the different etiologies but it ranges from simple pharmacological treatments to advanced laboratory procedures and surgeries. In developing countries, due to the lack of adequate equipment to diagnosis and treatment for many infertility causes and also probable long-term diagnosis process, many people tend to use alternative and complementary medicine [10]. Herbal medicines are one of the main modalities used in this field. Withania somnifera, (WS) also known as ashwagandha, Indian ginseng, winter cherry, horse smell, Kaknaje Hindi, is a well-known medicinal plant in Solanaceae family used in traditional medicine in many countries such as Iran and India [11]. This plant is known to cure impotency and increase sex appeal and fertility when used solitarily or in combination with other medications [12, 13]. This wild plant grows in dry and hot-semiarid climate such as southern Mediterranean region, Canary Islands, and northern Africa to northern India (Iran, Jordan, Sudan, Palestine, Afghanistan, and Egypt) [14, 15]. Different parts of this plant such as roots, leaves, flowers, seeds, stems, and fruits are used as remedy in traditional medicine of different countries [16-18]. Many phytochemicals have been extracted so far from this plant with possessing different pharmacologic and biological properties [19]. WS has been recommended for management of polyarthritis, lumbago, painful swellings, premature ejaculation, oligospermia, plague, asthma, vitiligo, general debility, impotency, ulcers, uterine infection, leucorrhoea, hemorrhoid, and orchitis in traditional Persian medicine [60, 61]. All these therapeutic uses suggest its anti-inflammatory, aphrodisiac, semenogogue, and deobstruent features [62-65]. As far as there are no wide-spectrum and specific studies or systematic reviews about therapeutic effects of WS, on male and female reproductive system, the present study was trying to systemically review therapeutic effects of WS on reproductive system and fertility disorders.

2. Methods

2.1. Study Design and Search Strategy

In this systematic review which was performed in 2016, required data were gathered using databases such as Google Scholar, PubMed, Scopus, Web of Science, and Cochrane Library. The keywords used in present study were “Withania somnifera” (also equivalent terms), “fertility”, “conceive”, “infertility”, “women”, “men”, “female”, “male”, “semen”, “sperm”, “spermicidal”, “Sertoli”, “prolactin”, “follicular stimulating hormone”, “luteinizing hormone”, “testosterone”, “libido”, “aphrodisiac”, “behavior”, “sexual”, “spermatogenesis”, “reproduction”, “semenogogue”, “impotency”, “spermatozoa”, “estrogen”, “pregnancy”, “gonadotropin releasing hormone”, “testis”, “leydig”, and “ovarian”. The time period between 1965 and 2017 was selected. Also, to increase the scope of the study, manual search in some of the valid journal databases was performed. All in vitro or in vivo studies about the effects of WS on reproductive system and fertility among human or animal subjects were included in the study. Review studies, case reports, letter to editors, and short communications were excluded from the study. To search for unpublished articles (grey literature), European Association for Grey Literature Exploitation (EAGLE) and Health Care Management Information Consortium (HMIC) were searched.

2.2. Articles Evaluation

The selected papers extracted from the databases were assessed by two investigators using Consort 2010 checklist. Discrepancies between the two raters were referred to the third investigator. First, the titles of all articles were reviewed to screen for eligibility and those found to be irrelevant with the objectives of the study were excluded from the study. In the later stages, the abstracts and full-text articles were, respectively, examined to identify and exclude those that did not match the inclusion.

2.3. Data Extraction

One reviewer extracted the data from the included studies while a second author checked the results. Any disagreements were resolved by a discussion of reviewers. Data for the primary objective of the review was collected from the full text of each publication and included the trial name, year of publication, type of study, sample size, results, and other characteristics.

2.4. Statistical Analysis

Statistical analysis was performed by SPSS software package version 16.0 for windows (SPSS Inc., Chicago, USA) [66]. Quantitative data are presented as mean ± standard deviation (SD), while qualitative data are demonstrated as frequency and percent (%).

3. Results

The flowchart of the study is shown in Figure 1. Of 459 recognized studies, 42 studies were included in the present study. These studies were composed of 8 human studies (7 studies on men and one among women), 28 animal studies (20 studies of male animals and 8 studies on female animals), 5 animal-cellular studies, and one cellular study. In these studies, roots (29 studies), leaves (7 studies), fruits (2 studies), unknown extract (2 studies), and stems (1 study) were used. Characteristics and results of human, animal, and animal-cellular studies are shown in Tables 1, 2, and 3, respectively. In all human studies, root extract was used. The duration of human studies ranged from 60 to 90 days. Mostly the WS extract was used orally and once daily in 50 percent of human studies. In the most studies, no side effects were found for WS extract during of studies [17, 20, 21, 30, 36, 40, 45, 46, 58].
Figure 1

Flowchart of the systematic review process searching for studies investigating Withania somnifera on reproductive system.

Table 1

Characteristics and results of human studies investigating effects of Withaniasomnifera on reproductive system.

NumberAuthor/yearDesignParticipantIntervention protocolDuration of studyResults PlacePart/compound
(1)Mahdi et al., 2011 [12]Controlled, prospective,before and after clinical trialNormozoospermic infertile men (N = 60); 3 groups; heavy smoker (n = 20), under psychological stress (n = 20), unknown etiology (n = 20), control fertile men (n = 60)5 g/d/PO/single dose with milk3 monthsNo marked change in semen volume, ↓ liquefaction time (p < 0.01, p < 0.05), ↑ sperm concentration (p < 0.01, p < 0.05), ↑ sperm motility in cigarette smokers and psychological stress groups (p < 0.05), ↑ LH, ↓ FSH, ↑ T, ↓ PRl, ↓ cortisol, ↓ LPO in seminal plasma and ↑ SOD in 3 groups (p < 0.01), ↑ CAT in psychological stress groups (p < 0.01), ↑ glutathione, ↑ ascorbic acid in psychological stress and unknown etiology groups (p < 0.01), ↑ vitamin E, ↑ vitamin A in 3 groups (p < 0.05) after treatment compared to before treatment, ↑ 14% rate of success of pregnancy in the partnersIndiaRoot powder

(2)Ambiye et al., 2013 [20]Double-blind, randomized, placebo-controlled clinical trial (a pilot study)Oligospermic infertile male (N = 46); 2 groups: WS (n = 21) and placebo (n = 25)675 mg: 1 capsule of 225 mg/thrice a day/PO90 days ↑ 53% semen volume, ↑ 167% sperm count, ↑ 57% sperm motility (p < 0.0001), ↑ 17% serum T (p < 0.01), ↑ 34% LH (p < 0.02) after 90 days of therapy compared to the baseline values on Day 0 GASE and GATE in WS-treated compared to placebo were excellent (68.75%)IndiaFull spectrumroot extract

(3)Dongre et al., 2015 [21]Double-blind, randomized, placebo-controlled clinical trial (a pilot study)Healthy married women (N = 50); WS (n = 25); placebo (n = 25)Capsules of 300 mg/twice daily/PO after food8 weeks ↑ total score (FSFI) (p < 0.001), ↑ FSFI domain score for “arousal” (p < 0.001), “lubrication” (p < 0.001), “orgasm” (p = 0.004), “satisfaction” (p < 0.001), ↑ FSDS score (p < 0.001), ↑ number of successful sexual encounters (p < 0.001) after treatment compared to placebo PGART and PGATT in both groups were excellent, no toxic effect during 8 weeks in WS-treated groupIndiaHigh-concentration root water extract

(4)Mamidi et al., 2014 [22]Randomized, single-blind, placebo-controlled, parallel-group studyMen with ED (N = 86); 2 groups: WS (n = 41) and placebo (n = 45)Four tablets 500 mg thrice a day (6 g)/PO after food60 days ↑ 10.52% on EDSI, ↑ 4.18% on IMHQOL, ↑ 39.22 on QEQ in WS group, ↑ 11.20% on EDSI, ↑ 5.95% on IMHQOL, ↑ 45.74% on QEQ (p < 0.001) in control group. No marked difference between two groups on all the scales (p > 0.05). No significant effect in length, circumference, angle of erection of penis after treatment between both groupsIndiaRoot powder

(5)Shukla et al., 2011 [23]Controlled, prospective,before and after clinical trialInfertile men (N = 75); 3 groups: NZ (n = 25), OZ (n = 25), AZ (n = 25) and control, healthy fertile men (n = 75)5 g/day/single dose with milk3 months↓ Sperms apoptosis in NZ and OZ men, ↓ ROS of spermatozoa in OZ and AZ infertile men (p < 0.05), ↑ metal ions concentration (Cu2+, Zn2+, Fe2+, Au2+) of seminal plasma in 3 groups (p < 0.01) after treatment comparison to before treatmentIndiaRoot powder

(6)Gupta et al., 2013 [24]Controlled, prospective, before and after clinical trialInfertile men (N = 180); 3 groups:NZ (n = 60), OZ (n = 60), AZ (n = 60) and control, healthy fertile men (n = 50)5 g/day/PO/single dose with milk3 months ↑ sperm concentration, ↑ sperm motility, ↓ LPO, ↑ LH, ↑ T (p < 0.01), ↓ FSH, ↓ PRL, ↑ ALT, ↑ AST, ↑ LDH, ↑ IDH, ↑ alanine, ↑ glutamate, ↑ citrate, ↑ GPC, ↑ histidine, ↓ phenylalanine in seminal plasma, after treatment compared to before treatment in NZ, OZ, AZ groups (p < 0.05)IndiaRootpowder

(7)Ahmad et al., 2010 [25]Controlled, prospective, before and after clinical trialInfertile men (N = 75); 3 groups:; NZ (n = 25), OZ (n = 25), AZ (n = 25) and control, healthy fertile men (n = 75)5 g/day/PO with milk3 months ↑ sperm concentration, ↑ sperm count (p < 0.01), ↑ sperm motility, ↓ LPO (p < 0.01), ↑ SOD, ↓ protein carbonyl groups in seminal plasma (p < 0.01), ↑ CAT (p < 0.01), ↑ glutathione (p < 0.01), ↑ vitamins A, E, and C (p < 0.01), ↑ seminal fructose (p < 0.05), ↑ T (p < 0.01), ↑ LH, ↓ FSH, ↓ PRL in all of the groups of infertile men after treatment compared to before treatment, ↑ semen volume in NZ and OZ groups after treatments compared to before treatmentsIndiaRootpowder

(8)Mamidi and Thakar, 2011 [26]Randomized, single-blind, placebo-controlled, parallel-group studyMen with ED (N = 86); 2 groups: WS (n = 41) and control (n = 45)Four tablets 500 mg/PO/thrice a day after food60 days ↑ 12.6% IIEF in WS-treated and ↑ 19.11% in placebo group (p < 0.001), no significant effect in the management of psychogenic erectile dysfunction and IIEF in WS-treated group compared to placebo group (p > 0.05)IndiaRoot powder

ND, not determined; WS, Withania somnifera; FSH, follicular stimulating hormone; LH, luteinizing hormone; ALP, alkaline phosphatase; Cd, cadmium; GSH, glutathione peroxidase; SOD, superoxide dismutase; CAT, catalase; MDA, malondialdehyde; STD, seminiferous tubules diameter; T, testosterone; PRL, prolactin; LPO, lipid peroxidation; GABAAg, amino butyric acid; TG, triglyceride; EDSI, erectile dysfunction severity index; FSFI, female sexual function index; FSDS, female sexual distress scale; IMHQOL, Internet mental health quality of life scale; QEQ, quality of erection questionnaire; NZ, normozoospermic; OZ, oligozoospermic; AZ, asthenozoospermic; IDH, isocitrate dehydrogenase; LDH, lactate dehydrogenase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GPC, glycerophosphocholine; IIEF, international index of erectile function; PGART, patient's global assessment of response to therapy; PGATT, patient's global assessment of tolerability to therapy; GASE, global assessment scale for efficacy; GATE, global assessment scale for tolerability; ↑, increase; ↓, decrease.

Table 2

Characteristics and results of animal studies investigating effects of Withaniasomnifera on reproductive system.

NumberAuthor/yearPlant extractParticipantIntervention protocolDurationof studiesResults Place
(1)AL-Qarawi et al., 2000 [27]Lyophilized aqueous extractImmature female Wistar rats (N = 60); 6 groups:17-day-old rats; G1 (10), G2 (10), control (n = 10), 25-day-old rats G1 (n = 10), G2 (n = 10), control (n = 10) G1 = C. coccineumG2 = W. somnifera47 mg/100 g bodyweight/stomach tube6 daysIn 25-day-old rats; ↑ FSH levels (p < 0.05), ↑ ovarian weight and deep folliculogenesis and proliferation of granulosa (p < 0.01) In 17-day-old animals; ↑ body weight (p < 0.01) no significant changes in the ovarian weight and folliculogenesis and FSH and LHKingdom of Saudi Arabia

(2)Mali et al., 2008 [28]50% ethanolic extractof fruitsFertility proven, adult healthy male albino rats50 mg/kg/PO/day60 days ↓ sperm motility, ↓ density of testicular and caudaepididymal sperms, ↓ weight of testes and seminal vesicle, ↓ ascorbic acid, ↓ sialic acid, ↓ cholesterol, ↓ protein, ↓ fructose, ↓ acid phosphatases, ↑ degenerative changes in the seminiferous tubules and germinal epithelium, ↓ spermatogenic elements, in treated ratsIndia

(3)Belal et al., 2012 [29]Root powerAdult male albino rats (N = 40); alloxan induced diabetes; 4 groups: control (n = 10), nondiabetic WS-treated (n = 10), diabetic rats (n = 10), diabetic group treated with WS (n = 10)Mixed with basal diet at ratio of 6.25%/po4 weeksNo significant alteration estrogen and cholesterol in treated with WS both diabetic and nondiabetic rats compared to controls groups (p < 0.05), ↑ progesterone in both diabetic and nondiabetic treated with WS (p < 0.05), ↑ T (p < 0.05), ↑ LH (p < 0.001) in nondiabetic treated with WS groups compared to the control group, ↓ TG in diabetic treated with WS compared to diabetic rats (p < 0.05), ↓ FSH in WS-treated groups (p < 0.05), not considered hypoglycemic effectEgypt

(4)Ilayperuma et al., 2002 [30]Methanolic extract of rootsProven fertility, adult male Wistar rats (N = 40); 4 groups:control 1, control 2 (n = 20) and WS 1, WS 2 (n = 20)3000 mg/kg/PO/day7 daysConsiderable weakness in libido, sexual performance, sexual vigour, and penile erectile dysfunction, no marked change in SGOT, SGPT, urea nitrogen, pH of the seminal vesicular fluid, wet weight of the organs and no deaths in treated periodSri Lanka

(5)Abdel-Magied et al., 2001 [31]Lyophilized aqueous extracts of leavesImmature male Wistar rats (N = 30); 3 groups: control (n = 10), C. coccineum (n = 10), WS (n = 10)47 mg/100 g body weight/d/stomach tube6 days ↑ LH, ↓ FSH, ↓ T, ↑ testicular weight, ↑ STD, ↑ number of seminiferous tubularcell layers (CL) and diameters, ↑ spermatogenesis in treated groups compared to control groupSaudi Arabia

(6)Dhas et al., 2015 [32]EthanolicextractsFemale and male fish (Etroplussuratensis); 4 groups:control and WS with different ratio + M. pruriens + Moringa oleifera120-200-300 mg/kg WS thrice in a dayND ↑ Gonadosomatic Index (GSI), ↑ fecundity, ↑ striping response, ↑ percentage of fertilization, ↑ percentage of hatching, ↓ percentage of deformed, ↑ formed larvae, ↑ volume of milt, ↑ number of sperm cell, ↑ percentage of sperm motility, ↑ sperm survival time, ↑ percentage of active sperm after treatment diets especially the EXD3 contain 300 mg/kg (p < 0.05)India

(7)Shaikh et al., 2015 [33]Glycowithanolides extract of fresh leavesAdult Swiss albino male mice (N = 32); 4 groups:D-galactose treated (n = 8), control (n = 8), protective (n = 8), curative (n = 8)20 mg/kg/injected subcutaneously20 days ↑ epididymal sperm count (p < 0.01), ↑ weight of testes and epididymis and body (p < 0.01) and returned to normal histology of testes in protective and curative group compared to D-galactose treated group and no significant increase in weight of testes, epididymis and seminal vesicle in the curative compared to protective groupIndia

(8)Kumar et al., 2015 [15]Ethanolic root extractMales Charles Foster rats (N = 30); arsenic induced testicular toxicity; 3 groups: control (n = 6), arsenic and WS-treated (n = 24)100 mg/Kg/PO/day30 days ↑ sperm count, ↑sperm motility, ↑ T, ↓ LH, ↓ LPO (p < 0.001), normalization the spermatogenetic stages, after treatment compared to before treatmentIndia

(9)Walvekar et al., 2013 [34]Glycowithanolides extract of fresh leavesAdult Swiss albino male mice (N = 20); 4 groups: D-galactose (n = 5), control (n = 5), protective (n = 5), curative (n = 5)20 mg/kg injected subcutaneously20 days↓ total and mitochondrial LPO, ↓ fluorescence product in testes, epididymis and seminal vesicle in protective and curative groups (p < 0.0001) compared to D-galactoseIndia

(10)Kumar et al., 2015 [35]Alcoholic root extract (5)%Female Swiss albino mice; chlorpyrifos induced toxicity ovaries; 4 groups: control, chlorpyrifos, WS, curcuma50 mg/kg/day8 weeks ↓ estrogen, ↓ cholesterol and restoration in germinal epithelium, graafian follicles and corpus luteum of ovary in WS-treated group compared to chlorpyrifos groupIndia

(11)Patil et al., 2012 [36]Ethanolic extract of fresh leavesHealthy male albino mice (N = 12); D-galactose induced stress; 3 groups: D-galactose (n = 6), control (n = 6), WS + D-galactose (n = 6)2% extract15 days ↓ total and mitochondrial LPO, ↑ sperm count, recovery of degenerative changes in histological structure both testis and epididymis after the treatment WS compared with D-galactose groupIndia

(12)Rajashree et al., 2011 [37]Alcoholic root extractMale albino rats (N = 24); streptozotocin-induced diabetic; 4 groups: STZ (n = 6), normalControl (n = 6), WS + STZ (n = 6), STZ + insulin (n = 6)500 mg/kg/PO/day30 days↑ weight of testes, ↑ caudal sperm count, ↑ weight of cauda epididymis in WS-treated diabetics compared to insulin treated groupsIndia

(13)Kiasalari et al. 2009 [38]Root powderWistar male rats (N = 39): ZTZ induced diabetic; 4 groups: ZTZ (n = 9), control (n = 8), WS + STZ (n = 11), sham (n = 11) Plant-mixed pelleted food at ratio of 6.25%/po/day4 weeks ↓ FSH (p < 0.05), ↑ LH (p < 0.05), ↑ progesterone (p < 0.05), ↑ T (p < 0.05), nonsignificant changes on estrogen in somnifera-treated diabetic, nondiabetic group compared to nontreated diabetic and nondiabetic, ns difference glucose, cholesterol after WS treatment, ↓ TG in somnifera-treated diabetic groupIran

(14)Rahmati et al., 2016 [39]Root powderMale rats (N = 48); 4 groups: morphine induced addiction: addicted (n = 12),control (n = 12),WS-treated control (n = 12), WS-treated addicted (N = 12)Plant-mixed pelleted food at ratio of 6.25%(0.3 ± 0.01 g/kg/day)21 days↑ estrogen in WS-treated control groups (p < 0.05) compared to control group, no marked effect in addict group, ↑ T, ↑ LH in WS-treated addicted group (p < 0.05) compared to control and addicted groups, ↑ FSH in WS-treated control group compared to control group (p < 0.05)Iran

(15)Prabu et al., 2014 [40]Hydroalcoholic root extractMale Wistar rats (N = 12); 2 groups: control (n = 6) and WS (n = 6)1000 mg/kg/PO (gavage)70 days ↓ WBC, ↓ LYM values (p < 0.05), ↑ insignificant neutrophil, ↑ RDW, ↓ monocyte, ↓ eosinophil, ↓ RBC counts, ↓ PCT values, no significant difference in body weight, testes and seminal vesicles weight, sperm count, morphology and biochemical parameters between treated group and control group (p < 0.05). No side effects in during treatmentIndia

(16)Bhargavan et al., 2015 [41]Ethanolic root extractHealthy adult male Wistar rats (N = 24); 4 groups: ethanol induced oxidative damage in the testes (n = 6), control (n = 6), WS + alcohol (n = 6), WS (n = 6)200 mg/PO/day28 days↑ testicular weight, ↑ body weight and recovered histopathological changes in the seminiferous tubules, ↑ sperm count, ↑ motility, ↓ sperm abnormality, ↓ MDA (p < 0.01), ↑ GSH (p < 0.01), ↑ CAT (p < 0.01), ↑ T in alcohol + WS cotreatment group compared with alcohol groupIndia

(17)Nirupama and Yajurvedi, 2015 [42]Chloroform and ethanolic extracts of rootsAdult male rats (N = 30); 6 groups: chronic stress exposed on testis (n = 5), control (n = 5), positive control (n = 5), stress + ethanolic WS (n = 5), stress + mifepristone (n = 5), stress + chloroform extract of WS (n = 5)10 mg/kg/day/orally (intubation)1 month↑ testicular 3β HSDH activity, ↓ adrenal 3β HSDH activity (p < 0.05), ↓ abnormal sperm count (p < 0.05), ↓ MDA, ↑ T (p < 0.05), ↑ total epididymal sperm count (p < 0.05), ↑ spermatogenesis, ↑ (SOD, CAT, GPx, GST, GR), ↑ ascorbic acid, tocopherol in WS-treated group compared to stressed ratsIndia

(18)Kumar et al., 2013 [43]Alcoholic extract of rootFemale Swiss albino mice (N = 36); chlorpyrifos induced toxicity of ovary; WS + chlorpyrifos (n = 30); control (n = 6)50 mg/kg/day8 weeks ↓ estrogen and cholesterol (p < 0.0001), recovery of ova, granulosa cells, germinal epithelium, mature graafian follicle, mitochondrial cristae of ovary and chromatin material after WS administration compared to before treatmentIndia

(19)Kumar et al., 2012 [44]Aqueous extract of rootsMale mice (N = 20); endosulfan exposed spermatozoa; 2 groups: control (n = 10) and endosulfan + WS (n = 10)1000 mg/kg/day8 weeks ↓ MDA, ↑ T, ↓ calcium, restoration of spermatozoa structure such as normal plasma and nuclear membrane, Golgi complex, chromatin material and mitochondrial cristae after WS treatment compared to before treatmentIndia

(20)Kaspate et al., 2015 [45]Hydroalcoholic extract of rootsHealthy female Wistar rats with tubal ligated (N = 24): 4 groups with various doses of WS100, 200 and300 mg/kg/PO/day21 days↑ sexual behavior, ↓ run time, ↑ proximity time, ↓ retreats (p < 0.05, p < 0.01), ↑ serum estradiol with doses 200 and 300 mg/kg (p < 0.05, p < 0.01), normalization in histology of genital organs like vagina, uterine horn and ovary in estrous female rats compared to estrous control female ratsIndia

(21)De and Chakraborty, 2016 [46]Root powderMixed-sex juveniles of Niletilapia (Oreochromisniloticus) (N = 360); 9 groups: control (n = 40) and WS with various concentration (n = 320)0.0, 2.0, 3.0, 3.5, 5.0, 6.5, 7.0, 8.0, 9.5 g/kg mixed food30 daysConcentrations up to 7.0 g/kg have no side effect (p < 0.05), ↑ percentage of male and ↓ percentage of female with any concentration of WS (p < 0.05), high percentage of survival and male were at the concentration of 6.5 g/kg compared to control groupIndia

(22)Jasuja et al., 2013 [47]Methanolic extract of leaves and rootsMale albino rats (N = 36); 6 groups: control (n = 6), acephate for 15 days (n = 6), acephate for 30 days (n = 6), acephate for 15 days + WS for 15 days (n = 6), acephate + WS for 30 days (n = 6), acephate for 15 days and no treatment for next 15 days (n = 6)100 mg/kg/PO/day15–30 days ↓ testicular LPO, ↑ GSH, ↑ SOD, ↑ CAT, ↑ T, ↑ FSH, ↑ LH (p < 0.01, p < 0.05), recovery of sperm count, motility, morphology, testis histology after WS treatment compared with acephate groupsIndia

(23)Saritha et al., 2011 [48]Leaf powder-mixed pelleted foodFemale rats (N = 35); 5 groups: control (n = 7), 0.05% Pb + normal pellet diet (n = 7), 0.05% Pb + WS diet (n = 7), 0.15% Pb + normal pellet diet (n = 7), 0.15% Pb + WS diet (n = 7)500 mg/kg/PO/day45 days ↓ length of the diestrus phase (p < 0.001), ↑ the number of implantations (p < 0.001), ↑ the number of live foetuses (p < 0.001), ↓ pre- and postimplantation losses after treatment with WS compared with the rats exposed and no toxicity in all of animals during treatmentIndia

(24)Garg and Parasar, 1965 [49]Root powerAlbino mice of either sex (N = 16); 2 groups: control (n = 8) and WS group (n = 8)25 mg/PO/day10 days ↓ fertility rate by 25%, ↓ mating behavior, ↓ number of pups per litter from 5.25 to 3.0 in WS treatment group compared to control groupIndia

(25)Sahin et al., 2016 [50]Hydroalcoholic extract of rootsMale rats (N = 35); 5 groups: control (n = 7), sildenafil-treated (n = 7), Mucuna (n = 7), Tribulus (n = 7), WS (n = 7)300 mg/kg/PO/day8 weeks No significant changes in body weight and reproductive organ weights, abnormal sperms, serum biochemical and hematology parameters (p > 0.05), ↓ mounting latency and intromission latency (p < 0.0001), ↑ mounting frequency and intromission frequency values (p < 0.0001), ↑ sperm counts, ↑ sperm motility, ↓ MDA, ↑ T (p < 0.0001) in WS groups compared to control groupTurkey

(26)Shaikh et al., 2014 [51]Glycowithanolides extract of fresh leavesAdult Swiss albino male mice (N = 32); 4 groups:D-galactose treated (n = 8), control (n = 8), protective (n = 8), curative (n = 8)20 mg/kg/injected subcutaneously20 days↑ SOD, ↑ GPx, ↑ CAT in testes and accessory reproductive organs (p < 0.01) in protective and curative group compare to D-galactose groupIndia

(27)Saiyed et al., 2016 [52]Hydroalcoholic extract of rootsFemale Wistar rats (N = 24); letrozole induced PCOS: 4 groups: negative control (n = 6), positive control (n = 6), WS and TT (n = 6), standard group with clomiphene citrate (n = 6)198 mg/kg28 days↑ number of days in estrus phase (p < 0.05), ↓ duration of diestrus phase in test group (p < 0.01) returned to normalcy on ↑ FSH, ↓ LH, ↓ T, ↓ estradiol and recovery of ovary and uterine weight but no significant, ↓ cholesterol (p < 0.01) compared to positive control groupIndia

(28)Mali, 2013 [53]Hydroalcoholic extractof fruitsHealthy, male albino rats (N = 12); 2 groups: control (n = 6) and WS (n = 6)200 mg/kg/day/po60 days ↓ primary and secondary spermatocytes, mature sperms, ↓ weight of testis and other accessory reproductive organs, ↑ abnormal seminiferous tubules, ↓ protein, ↓ sialic acid, ↓ fructose, ↓ ascorbic acid (p < 0.01, p < 0.001) in WS groups compared to control groupIndia

ND, not determined; WS, Withania somnifera; FSH, follicular stimulating hormone; LH, luteinizing hormone; ALP, alkaline phosphatase; Cd, cadmium; GSH, glutathione peroxidase; SOD, superoxide dismutase; CAT, catalase; MDA, malondialdehyde; STD, seminiferous tubules diameter; T, testosterone; PRL, prolactin; LPO, lipid peroxidation; GABAA g, amino butyric acid; TG, triglyceride; EDSI, erectile dysfunction severity index; FSFI, female sexual function index; FSDS, female sexual distress scale; IMHQOL, Internet mental health quality of life scale; QEQ, quality of erection questionnaire; NZ, normozoospermic; OZ, oligozoospermic; AZ, asthenozoospermic; IDH, isocitrate dehydrogenase; LDH, lactate dehydrogenase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GPC, glycerophosphocholine; TT, Tribulus terrestris; WBC, white blood cell; LYM,lymphocytes.; ↑, increase; ↓, decrease.

Table 3

Characteristics and results of animal-plant and cellular studies investigating effects of Withaniasomnifera on reproductive system.

NumberAuthor/yearType of studyParticipantIntervention protocolPlant/extractDuration of studiesResultsPlace
(1)Bhattarai et al., 2010 [54]In vitroGnRH neurons of male and female juvenile mice brain (N = 20) under patch clamp techniqueBath application of the 400 ng/μl under condition of high clMethanolic extract of root powderND Production of potent membrane depolarization of the GnRH neurons, ↑ spontaneous action potentials, ↑  GABAA memetic activityRepublic of Korea

(2)Kataria et al., 2015 [55]In vitro & in vivo(animal)Rat hypothalamic GnV-3 cells & Wistar adult male rats (N = 6); 2 groups: control (n = 3) and WS (n = 3)In vitro: 0.05–1.5% ASH-WEX In vivo: 4 ml/kg ASH-WEX/oral routeAqueous extract of leaves24 h & 21 daysIn vitro: significant changes in morphology and physiological in GnV-3 as cell body size and neurite process, ↓ LDH levels at higher concentrations of WS, ↑ release of GnRH extra cellularly in the GnV-3 cells after treatment with WS, no elevated cytotoxicity, viable of 61.2% of cell after WSIn vivo: no marked difference in GnRH level in WS-treated as compared to control group but upregulation of GnRH expression after treatment with WSIndia

(3)Singh et al., 2013 [56]In vitro & in vivo (animal)Rat semen & proven fertility, male albino rat (N = 18); 3 groups: control (n = 6), WS 25 mg (n = 6), WS 50 mg (n = 6)2, 4, 6, 8, 10, 25 & 50 mg/kg/day/orallyEthanolic extract of stems20 s & 60 daysIn vitro: minimum effective concentration of WS to kill 1 million sperm in 20 s was around 10 ± 0.066In vivo: ↓ sperm density of cauda epididymal sperms, ↓ weight of testes, ↓ epididymis and seminal vesicle, ↓ spermatogenesis, ↓ sperm motility of cauda epididymal sperms, ↓ seminiferous tubules size, ↓ leydig cell nuclei diameter, ↓ seminiferous tubular diameter, ↓ rate of fertility in high dose WS and no considerable changes in T, FSH, sperms morphology, serum biochemistry, hematological parameters, body weight compared to control groupIndia

(4)Ganu et al., 2010 [57]In vitro & in vivo (animal)Healthy male rats (N = 6) & adult male mice (N = 48); 8 groups: control (n = 6), abutilon indicum with various doses (n = 18), WS with various doses (n = 18), sildenafil (n = 6) 1 mg/ml & 100, 200, 400 mg/kg/POAqueous extract of roots28 d ↑ sperm count in all groups (p < 0.01), ↑ mounting frequency (p < 0.05) with WS 200, 400, ↑ frequency of penile erection episodes (p < 0.05), ↑ number of female licking behaviors with WS 400 (p < 0.01), ↑ mating behavior with WS 400 (p < 0.05), ↑ body weight with WS 400 (p < 0.01), ↑ testes weight, ↑ weight of prostate with WS 400, 200 (p < 0.01) compared to controlIndia

(5)Prithiviraj et al., 2013 [58]In vitro & in vivo (animal)Male Wistar albino rats (N = 30); 5 groups: cadmium-induced oxidative injury in testis (n = 6), control (n = 6), cadmium + WS (n = 6), cadmium and vitamin E (n = 6), control and WS (n = 6)300 mg/kg dissolved in 2% gum acacia /gavageRoot power30 days ↑ SOD (p < 0.05), ↑ CAT (p < 0.01), ↑ GPX (p < 0.01), ↑ GSH (p < 0.001), ↑ levels of Vit C (ascorbic acid) (p < 0.05), Vit E (αtocopherol) (p < 0.01), ↓ ROS, ↓ LPO, ↓ caspase-3 in Cd + WS testis compared to Cd testis, ↓ GST (p < 0.05) in Cd + WS compared to normal level, ↓ apoptotic cells (p < 0.001), ↑ weight and volume of testes, ↑ leydig cell number (p < 0.05), ↓ necrotic or pathological change of testes in Cd + WS compared to control, no toxic side effect, stress, changes in behaviorIndia

(6)Kyathanahalli et al., 2014 [59]In vitro & in vivo (animal)Prepubertal male rats (N = 18); 3 groups: streptozotocin-induced testicular oxidativeimpairments (n = 6), control (n = 6), STZ + WS (n = 6)500 μg & 500 mg/kg/day/oralgavageAqueous root extract15 daysIn vitro: considerable inhibition of deoxyribose and stable free radical DPPHIn vivo: ↓ LPO, ↓ ROS in testis cytosol 38%, mitochondria 24% of STZ + WS groups but no marked change, ↑ total Thiol (TSH, GSH), ↑ nonprotein thiol (NPSH) in testis cytosol and mitochondria, ↑ weights of testis, ↓ blood glucose of STZ + WS group compared to STZ group (p < 0.05)India

ND, not determined; WS, Withania somnifera; FSH, follicular stimulating hormone; LH, luteinizing hormone; ALP, alkaline phosphatase; Cd, cadmium; GSH, glutathione peroxidase; SOD, superoxide dismutase; CAT, catalase; MDA, malondialdehyde; STD, seminiferous tubules diameter; T, testosterone; PRL, prolactin; LPO, lipid peroxidation; GABAA g-amino butyric acid; TG, triglyceride; EDSI, erectile dysfunction severity index; FSFI, female sexual function index; FSDS, female sexual distress scale; IMHQOL, Internet mental health quality of life scale; QEQ, quality of erection questionnaire; NZ, normozoospermic; OZ, oligozoospermic; AZ, asthenozoospermic; IDH, isocitrate dehydrogenase; LDH, lactate dehydrogenase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GPC, glycerophosphocholine; ↑, increase; ↓, decrease.

Many phytochemicals have been extracted from WS, which includes alkaloids, flavonoids, steroidal lactones, saponins, neurotransmitters, essential and nonessential fatty acids, ergostane, and gamma amino butyric acid; of all these components, alkaloids, and withanolids such as withaferin A, withanosides, sitoindosides, beta-sitosterol, and various amino acids like alanine have more prominent effect on fertility status [20, 23–25, 28–30, 34, 38, 51, 55]. In animal studies, WS is known to have gonadotropic function which increases gonadal weight by growthing follicles size in female and also increasing seminiferous tubular cell layers in male animals [27, 28, 31, 33, 35, 37, 41, 57–59]. WS is found to improve spermatogenic activity which is proposed to be due to supporting hypothalamic-hypophysial-gonadal hormonal axis and testosterone balance in testes [15, 31, 42]. WS is found to compensate LH and FSH decrease or increase in diabetic Wistar rats [27, 29, 31, 38, 47]. Also, WS increases testosterone [15, 29, 38, 39, 44, 47] and progesterone [29, 38] in male rats and decreases triglyceride and cholesterol in both male and female rats [28, 29, 35, 38, 43, 52]. In a study by Shukla et al. about effects of WS on men, WS root powder was used for 3 months and it was shown that sperm parameters such as count and motility in sperm analysis had improved due to decrease apoptosis and reactive oxidative stress among men with normospermia and oligospermia; also copper, zinc, iron, and gold ions of seminal plasma had increased after the treatment and subsequently semen quality increased. This increase in semen quality is proposed to be due to the increase in essential neurotransmitters, metallothionein which has antioxidative function, and metal ions as cofactors for essential enzymes [23]. In two clinical trials, the effects of 5 grams of WS root for 3 months on semen parameters of infertile men were investigated. Improvement in semen quality, increased vitamins E, C, and A, and increased fertility were reported which is proposed to be due to the high amount of alkaloids, ergostane steroids, and essential amino acids in WS which improved detoxification, decreased oxidative stress, and restorated testosterone secretion [12, 25]. In another human study, treatment by WS aqueous extract in married healthy women increased their sexual function index and diminished sexual distress index statistically significant [21]. In two studies using WS root extract for men with psychologic erectile dysfunction, there was no statistically significant difference between the intervention and control group considering sexual function indices [22, 26]. Also, WS root extract was found to decrease prolactin level after 3 months of administration among infertile men [12, 24, 25]. In a study by Bhattarai et al. about effects of WS root extract, it was found that GABA mimetic features of this extract led to an increased activity of gonadotropin releasing hormone secreting neurons [54]. On the other hand, WS root extract was found to decrease libido and sexual function which led to impotency and erectile dysfunction in animal studies [30]. Ethanolic WS fruit and stem extract were found to induce infertility in male rats due to the decrease in sperm motility, count, and degeneration of seminiferous tubules, although this extract did not have an effect on sperm morphology [28, 53, 56]. Prabu et al. in a study on male rats found that hydroalcoholic WS root extract was found to decrease white blood cell and lymphocyte counts in blood, but no considerable effect on reproductive indices [40]. Alcoholic WS root extract can decrease estrogen and cholesterol level in female Wistar mice and recover corpus luteum, graafian follicles, and germinal epithelium which has been damaged due to the chlorpyrifos exposure [35]. WS leaves and roots have been found to improve oxidative stress indices such as an increase in superoxide dismutase, catalase, glutathione, lactate dehydrogenase, alanine, glutamine, phenylalanine, and decrease in cortisol and fructose [12, 22–25, 34, 36, 47, 51, 58]. In a study investigating effects of 6.5 mg of WS root extract on Nile tilapia, it was found that this extract with androgenic effects decreased prolactin level and estrogen level by inhibiting aromatase activity and induced male phenotype formation; this phenomenon was proposed to be due to components such as tannin, saponins, terpenoids, steroids, and flavonoids [46].

4. Discussion

Traditional and complementary medicine have been more popular nowadays to cure health related conditions [67]. This proposes a new strong potential in traditional and complementary medicine to come up with new medical combinations with fewer side effects [68-70]. Traditional Persian medicine is one of the most well-known categories of traditional medicine using herbal medicine as one of the main therapeutic modalities [71]. Withania somnifera is one of the herbal medicines widely used for the treatment of infertility and sexual dysfunction. This plant has been known to contain more than 80 types of phytochemicals such as steroidal and nonsteroidal alkaloids, steroidal lactones and saponins like isopelletierine, anaferin, anahygrine, hygrine, cuscohygrine, tropine, pseudotropine, withananine, ashwagandha, withaferins, withananinine, pseudowithanine, somnine, somniferine, somniferinine, 3-tropyltigloate, withanine, withasomine, visamine, mesoanaferine, sitoindoside (7–10), hentriacontane, amino acids such as aspartic acid, glycine, tryptophan, proline, alanine, tyrosine, hydroxyproline valine, cystine, glutamic acid, and cysteine, calcium, phosphorus, iron, flavonoids, starch, reducing sugars, proteolytic enzyme “chamase,” glycosides, dulcitol, and volatile oil. Of all these components, withaferin A and sitoindosides had the key role in WS therapeutic effects [11, 13, 23, 33, 34, 60, 61, 72]. Based on the present study, it was shown that extracts of WS fruits, leaves, stems, and especially roots enhance sperm quality indices such as motility and count in men [12, 20, 24, 25] and also decrease the effects of chemical toxins on gonads in both men and women [13, 15, 29, 33–38, 41, 44, 45, 59]. WS can increase gonadal weight in both sexes, enhance folliculogenesis and spermatogenesis, and improve LH, FSH, and testosterone balances [15, 27, 31, 35, 36, 38, 42, 44, 45]. Sexual behavior indices such as female sexual function index and female sexual distress index improve statistically significant after WS extract administration [21]. The mechanism of WS effect on the reproductive system is not known entirely yet, but this mechanism is proposed to be linked to the antioxidative features and ability to improve the hormonal balance of LH, FSH, and testosterone and improve detoxification process. Also, the GABA mimetic feature of WS extract is thought to play the main role in inducing gonadotropin releasing hormone secretion and improving hormonal balance [23, 27, 31, 34–36, 42, 44, 47, 51]. In the male reproductive system, it is assumed that WS by providing metal ions facilitates enzyme activities, modifies oxidative stress, and prevents cell apoptosis [23]. The root extract of WS has been shown to induce alanine transaminase activity which increases alanine in seminal fluid leading to a less oxidative stress index and improved semen quality [24]. Normalizing lactate, phenylalanine, glutamine, citrate, and histidine in seminal fluid are another feature of WS extract which improves enzymatic processes in tricarboxylic acid cycle (TCA) and fatty acid metabolism [12, 59]. On the other hand, some animal studies have suggested that WS extract may cause reversible spermicidal and infertilizing effect in male and delayed puberty in both sexes; this might be due to the dose, preparation method, adjuvant components, and duration of use designated in mentioned studies [28, 30, 49, 53, 56].

5. Conclusion

Based on the results, it deems that Withania somnifera has a positive effect in the treatment of infertility both in male and female. Although some studies proposed that WS extract might have infertilizing and spermicidal effect. Due to the growing interest in using herbal medicine especially those which possess the antioxidative and reproductive system supporting properties, further studies are needed to be designed with higher population and more-structured methodology so a more precise and decisive conclusion can be made.
  29 in total

1.  International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care.

Authors:  Jacky Boivin; Laura Bunting; John A Collins; Karl G Nygren
Journal:  Hum Reprod       Date:  2007-03-21       Impact factor: 6.918

2.  Efficacy of Withania somnifera on seminal plasma metabolites of infertile males: a proton NMR study at 800 MHz.

Authors:  Ashish Gupta; Abbas Ali Mahdi; Kamla Kant Shukla; Mohammad Kaleem Ahmad; Navneeta Bansal; Pushplata Sankhwar; Satya Narain Sankhwar
Journal:  J Ethnopharmacol       Date:  2013-06-21       Impact factor: 4.360

3.  Withania somnifera aqueous extract facilitates the expression and release of GnRH: In vitro and in vivo study.

Authors:  Hardeep Kataria; Muskan Gupta; Sukhwinder Lakhman; Gurcharan Kaur
Journal:  Neurochem Int       Date:  2015-08-06       Impact factor: 3.921

Review 4.  The dynamic epigenetic program in male germ cells: Its role in spermatogenesis, testis cancer, and its response to the environment.

Authors:  Maren Godmann; Romain Lambrot; Sarah Kimmins
Journal:  Microsc Res Tech       Date:  2009-08       Impact factor: 2.769

5.  Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males.

Authors:  Mohammad Kaleem Ahmad; Abbas Ali Mahdi; Kamla Kant Shukla; Najmul Islam; Singh Rajender; Dama Madhukar; Satya Narain Shankhwar; Sohail Ahmad
Journal:  Fertil Steril       Date:  2009-06-06       Impact factor: 7.329

6.  Effects of glycowithanolides on lipid peroxidation and lipofuscinogenesis in male reproductive organs of mice.

Authors:  Madhuri Walvekar; Nilofar Shaikh; Priti Sarvalkar
Journal:  Iran J Reprod Med       Date:  2013-09

7.  Effect of combination of Withania somnifera Dunal and Tribulus terrestris Linn on letrozole induced polycystic ovarian syndrome in rats.

Authors:  Amrin Saiyed; Nasreen Jahan; Shaikh Ajij Ahmed Makbul; Mushir Ansari; Humaira Bano; Syeda Hajera Habib
Journal:  Integr Med Res       Date:  2016-10-19

8.  Phytoremedial effect of Withania somnifera against arsenic-induced testicular toxicity in Charles Foster rats.

Authors:  Arun Kumar; Ranjit Kumar; Mohammad Samuir Rahman; Mohammad Asif Iqubal; Gautam Anand; Pintoo Kumar Niraj; Mohammad Ali
Journal:  Avicenna J Phytomed       Date:  2015 Jul-Aug

9.  Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Improving Sexual Function in Women: A Pilot Study.

Authors:  Swati Dongre; Deepak Langade; Sauvik Bhattacharyya
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

10.  Comparative evaluation of the sexual functions and NF-κB and Nrf2 pathways of some aphrodisiac herbal extracts in male rats.

Authors:  Kazim Sahin; Cemal Orhan; Fatih Akdemir; Mehmet Tuzcu; Hasan Gencoglu; Nurhan Sahin; Gaffari Turk; Ismet Yilmaz; Ibrahim H Ozercan; Vijaya Juturu
Journal:  BMC Complement Altern Med       Date:  2016-08-26       Impact factor: 3.659

View more
  11 in total

Review 1.  A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.

Authors:  Eun-Ryeong Hahm; Su-Hyeong Kim; Krishna B Singh; Kamayani Singh; Shivendra V Singh
Journal:  Cancer Prev Res (Phila)       Date:  2020-07-29

2.  RNA-seq reveals novel mechanistic targets of withaferin A in prostate cancer cells.

Authors:  Su-Hyeong Kim; Eun-Ryeong Hahm; Krishna B Singh; Sruti Shiva; Jacob Stewart-Ornstein; Shivendra V Singh
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

Review 3.  The most important medicinal plants affecting sperm and testosterone production: a systematic review.

Authors:  Shakiba Nasiri Boroujeni; Farid Ansari Malamiri; Fatemeh Bossaghzadeh; Alireza Esmaeili; Emadoddin Moudi
Journal:  JBRA Assist Reprod       Date:  2022-08-04

Review 4.  Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases.

Authors:  Alexander G Panossian; Thomas Efferth; Alexander N Shikov; Olga N Pozharitskaya; Kenny Kuchta; Pulok K Mukherjee; Subhadip Banerjee; Michael Heinrich; Wanying Wu; De-An Guo; Hildebert Wagner
Journal:  Med Res Rev       Date:  2020-10-25       Impact factor: 12.944

5.  The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.

Authors:  Su-Hyeong Kim; Krishna B Singh; Eun-Ryeong Hahm; Shivendra V Singh
Journal:  Cancer Prev Res (Phila)       Date:  2021-01-28

6.  A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight Males.

Authors:  Adrian L Lopresti; Peter D Drummond; Stephen J Smith
Journal:  Am J Mens Health       Date:  2019 Mar-Apr

7.  Corrigendum to "Effects of Withania somnifera on Reproductive System: A Systematic Review of the Available Evidence".

Authors:  Ramin Nasimi Doost Azgomi; Afshar Zomorrodi; Hossein Nazemyieh; Seyed Mohammad Bagher Fazljou; Homayoun Sadeghi Bazargani; Fatemeh Nejatbakhsh; Arezoo Moini Jazani; Yadollah Ahmadi AsrBadr
Journal:  Biomed Res Int       Date:  2019-11-21       Impact factor: 3.411

Review 8.  Effects of Ashwagandha (Withania somnifera) on Physical Performance: Systematic Review and Bayesian Meta-Analysis.

Authors:  Diego A Bonilla; Yurany Moreno; Camila Gho; Jorge L Petro; Adrián Odriozola-Martínez; Richard B Kreider
Journal:  J Funct Morphol Kinesiol       Date:  2021-02-11

Review 9.  Critical review of the Withania somnifera (L.) Dunal: ethnobotany, pharmacological efficacy, and commercialization significance in Africa.

Authors:  Henok Kessete Afewerky; Ayeni Emmanuel Ayodeji; Bashir Bolaji Tiamiyu; Joshua Iseoluwa Orege; Emmanuel Sunday Okeke; Aanuoluwapo Opeyemi Oyejobi; Petuel Ndip Ndip Bate; Sherif Babatunde Adeyemi
Journal:  Bull Natl Res Cent       Date:  2021-10-21

10.  Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS).

Authors:  Siddharth J Modi; Anshuly Tiwari; Chetana Ghule; Sandeep Pawar; Ganesh Saste; Shubham Jagtap; Ruchi Singh; Amol Deshmukh; Aboli Girme; Lal Hingorani
Journal:  Molecules       Date:  2022-02-22       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.